Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Small Cap

Small Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Equities
  • General
  • Health Care
  • Initiation
  • Markets
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Patient Demand Drives Ardelyx’s Constipation Drug Success Amid IBS-C Treatment Gap, Says Analyst

By Vandana Singh
December 18, 2:14 PM
Raymond James initiated coverage of Ardelyx Inc (NASDAQ: ARDX), noting the company's two early-stage launches underway for the same molecule with differentiated pricing:

ARDX

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor
December 18, 2:05 PM
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.

ADD

Read More
4 minute read
  • Cannabis
  • Contracts
  • FDA
  • Global
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Biden’s Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More

By Lara Goldstein
December 18, 1:21 PM
Biden To Decide On Psychedelic Therapy Bill

ATAI

Read More
2 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Crude Oil Rises 3%; US Housing Market Index Increases In December

By Avi Kapoor
December 18, 1:17 PM
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500 also rose, gaining, 0.37% to 4,736.45.

BMRA

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap

Why Is COVID-19 Antibody Focused Invivyd Stock Trading Over 150% Higher Today?

By Vandana Singh
December 18, 12:55 PM
Invivyd Inc (NASDAQ: IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life extended monoclonal antibody candidate, for the prevention of 

IVVD

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Small Cap

Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?

By Vandana Singh
December 18, 12:47 PM
Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-res

LNTH

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Small Cap

Why Is Novo Nordisk’s Potential Obesity Drug Rival Structure Therapeutics Stock Tanking Today?

By Vandana Singh
December 18, 12:20 PM
Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development program update for its highly selective oral GLP-1 

GPCR

Read More
2 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday

By Avi Kapoor
December 18, 11:57 AM
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday.

CIFR

Read More
2 minute read
  • Asset Sales
  • Equities
  • M&A
  • Markets
  • Mid Cap
  • Movers
  • News
  • Small Cap

Why Window Company PGT Innovations Shares Are Surging Today

By Lekha Gupta
December 18, 11:50 AM
PGT Innovations Inc (NYSE: PGTI) and Masonite International Corp (NYSE: DOOR) shares are rising and declining, respectively, today following the acquisition deal. 

DOOR

Read More
2 minute read
  • Movers
  • News
  • Penny Stocks
  • Small Cap

SunPower Stock Is Tumbling: What’s Going On?

By Adam Eckert
December 18, 11:25 AM
SunPower Corp (NASDAQ: SPWR) shares are trading lower Monday after the company said substantial doubt exists about its ability to continue as a going concern.

SPWR

Posts pagination

Previous 1 … 119 120 121 … 1,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service